切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2023, Vol. 17 ›› Issue (06) : 615 -618. doi: 10.3877/cma.j.issn.1674-3946.2023.06.009

论著

尿碘水平与甲状腺乳头状癌患者术后复发危险度分层的相关性
崔占斌, 乔军利(), 张丽丽, 韩明强   
  1. 054001 河北邢台,邢台市人民医院头颈甲状腺外科
  • 收稿日期:2022-11-14 出版日期:2023-12-26
  • 通信作者: 乔军利

Correlation between urinary iodine levels and stratified risk of recurrence in patients with papillary thyroid cancer after surgery

Zhanbin Cui, Junli Qiao(), Lili Zhang, Mingqiang Han   

  1. Department of Head, Neck and Thyroid Surgery, Xingtai People's Hospital, Xingtai Hebei Province 054001, China
  • Received:2022-11-14 Published:2023-12-26
  • Corresponding author: Junli Qiao
  • Supported by:
    Hebei Provincial Health Department Youth Talent Fund Project(20201583)
引用本文:

崔占斌, 乔军利, 张丽丽, 韩明强. 尿碘水平与甲状腺乳头状癌患者术后复发危险度分层的相关性[J/OL]. 中华普外科手术学杂志(电子版), 2023, 17(06): 615-618.

Zhanbin Cui, Junli Qiao, Lili Zhang, Mingqiang Han. Correlation between urinary iodine levels and stratified risk of recurrence in patients with papillary thyroid cancer after surgery[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 615-618.

目的

探讨甲状腺乳头状癌(PTC)尿碘水平与患者术后复发危险度分层的关系。

方法

收集2017年1月至2020年12月期间接受手术治疗的500例PTC患者临床资料,统计患者术前检测尿碘水平及术后复发危险度分层,并根据患者术后3年内复发情况分为复发组(n=18)与未复发组(n=482),采用统计学软件SPSS 25.0分析数据,用Kendall's tau-b相关性检测术前尿碘水平与PTC复发危险度分层的关系;绘制ROC曲线分析术前尿碘水平对PTC患者术后复发的预测价值。P<0.05表示差异有统计学意义。

结果

500例PTC患者低危层312例,中危层142例,高危层46例;尿碘水平:高危组>中危组>低危组(P<0.05);Kendall's tau-b相关性分析显示,尿碘水平与甲状腺乳头状癌复发危险度分层呈正相关(r=0.135,P<0.05);500例PTC患者术后随访期间复发18例,复发组患者淋巴结转移占比及促甲状腺激素(TSH)、甲状腺免疫球蛋白(Tg)、抗甲状腺球蛋白抗体(TgAb)、尿碘水平均高于未复发组(P<0.05);ROC曲线结果显示,术前尿碘水平预测PTC患者术后复发的AUC>0.7,具有一定预测价值。

结论

术前尿碘水平与PTC患者复发密切相关,在PTC患者复发预测中具有一定价值。

Objective

To investigate the relationship between urinary iodine level and stratified risk of recurrence in patients with papillary thyroid carcinoma (PTC).

Methods

Clinical data of 500 patients with PTC who received surgical treatment from January 2017 to December 2020 were collected. Preoperative urinary iodine level and postoperative recurrence risk of patients were statistically stratified, and patients were divided into recurrence group and non-recurrence group according to the recurrence situation within 3 years after surgery. Statistical software SPSS 25.0 was used to analyze the data. Kendall's tau-b correlation was used to detect the stratified relationship between preoperative urinary iodine level and the risk of PTC recurrence. ROC curve was drawn to analyze the predictive value of preoperative urinary iodine level for postoperative recurrence in PTC patients. P<0.05 indicated that the difference was statistically significant.

Results

Among the 500 PTC patients, 312 cases were in low-risk layer, 142 cases were in middle-risk layer, and 46 cases were in high-risk layer. Urinary iodine level: high-risk group > medium-risk group > low-risk group (P<0.05); Kendall's tau-b correlation analysis showed that urinary iodine level was positively correlated with the risk of thyroid papillary carcinoma recurrence stratification (r=0.135,P<0.05). In the 500 PTC patients, 18 cases recurred during the follow-up. The lymph node metastasis ratio, thyroid stimulating hormone (TSH), thyroid immunoglobulin (Tg), anti-thyroglobulin antibody (TgAb) and urinary iodine levels in the recurrent group were higher than those in the non-recurrent group (P<0.05). ROC curve results showed that preoperative urinary iodine level predicted the AUC of postoperative recurrence in PTC patients to be greater than 0.7, which had certain predictive value.

Conclusion

Preoperative urinary iodine level is closely related to the recurrence of PTC patients, and has certain value in predicting the recurrence of PTC patients.

表1 500例PTC患者术前基线资料及病理特征比较[例(%)]
表2 500例PTC不同组别患者术前实验室血清学指标及尿碘水平比较()
图1 术前尿碘水平预测PTC患者术后复发的ROC曲线图
表3 术前尿碘水平预测PTC患者术后复发的价值分析
[1]
袁建明,刘涛,靳晓丽,等. 不同钙剂和维生素D3补充方案对甲状腺癌双侧甲状腺切除术后并发症及预后情况的影响[J/CD]. 中华普外科手术学杂志(电子版), 2020, 14(05): 522-525.
[2]
王勇,王玲. 甲状腺癌术后碘131联合甲状腺激素应用效果分析[J/CD]. 中华普外科手术学杂志(电子版), 2020, 14(06): 616-619.
[3]
周德梅,安冬,张念恒,等. 贵州省育龄妇女碘营养状况及血清促甲状腺激素水平调查[J]. 现代预防医学, 2020, 47(06): 1020-1023,1043.
[4]
中华医学会内分泌学分会,中华医学会外科学分会内分泌学组,中国抗癌协会头颈肿瘤专业委员会,等. 甲状腺结节和分化型甲状腺癌诊治指南[J]. 中华核医学与分子影像杂志, 2013, 33(02): 20.
[5]
徐志勇,马晓良. 甲状腺癌患者术后复发风险预测的列线图模型建立[J]. 实用肿瘤学杂志, 2021, 35(01): 35-40.
[6]
Sun JLi PChen X,et al. The influence of thyroid status,serum Tg,TSH,and TgAb on FNA-Tg in cervical metastatic lymph nodes of papillary thyroid carcinoma[J]. Laryngoscope Investig Otolaryngol, 2021, 7(1): 274-282.
[7]
张建,梁娴,赵春生. 甲状腺癌患者血清甲状腺球蛋白抗体,白细胞介素35及促甲状腺激素的水平及意义[J]. 检验医学与临床, 2020, 17(21): 3148-3150,3155.
[8]
王刚,谢丽娟,张明菊. 超声引导下颈淋巴结穿刺联合血清TSH,SIL-2R水平检测与甲状腺癌患者颈部淋巴结转移及疾病严重程度的关系[J]. 河北医科大学学报, 2020, 41(04): 436-439.
[9]
张佳藤,崔可飞,马笑,等. 超声造影联合血清甲状腺球蛋白抗体检测在甲状腺癌诊断中的应用价值[J]. 癌症进展, 2020, 18(10): 998-1008.
[10]
Adhami MMichail PRao A,et al. Anti-Thyroid Antibodies and TSH as Potential Markers of Thyroid Carcinoma and Aggressive Behavior in Patients with Indeterminate Fine-Needle Aspiration Cytology[J]. World J Surg, 2020, 44(2): 363-370.
[11]
李忠原,李春香,王恒阳,等. 齐齐哈尔市富拉尔基区常住居民甲状腺疾病患病现况及碘营养状态调查[J]. 中国地方病防治杂志, 2020, 35(04): 410-415.
[12]
王胤达,冯联忠. 嘉兴地区甲状腺结节手术患者尿碘浓度及其与甲状腺乳头状癌的关系[J]. 浙江医学, 2020, 42(19): 2089-2092.
[13]
陈畅,沈阳,吴永霞,等. 甲状腺摄碘率预测分化型甲状腺癌患者131I治疗后体内残留活度的价值[J]. 中华核医学与分子影像杂志, 2020, 40(10): 595-598.
[14]
Eder SHermann CLamkowski A,et al. A comparison of thyroidal protection by stable iodine or perchlorate in the case of acute or prolonged radioiodine exposure[J]. Arch Toxicol, 2020, 94(9): 3231-3247.
[15]
刘汉卿,陈创,涂毅,等. 钠碘同向转运体在分化型甲状腺癌中异常表达的研究进展[J]. 肿瘤学杂志, 2020, 26(12): 1068-1074.
[1] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[2] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[3] 谢田伟, 庞于樊, 吴丽. 超声引导下不同消融术对甲状腺良性结节体积缩减率、复发率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 80-83.
[4] 孙莲, 马红萍, 吴文英. 局部进展期甲状腺癌患者外科处理[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 112-114.
[5] 麻紫月, 王贞文, 张强, 赵代伟, 张翊伦. 右侧喉不返神经1例报告[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 115-116.
[6] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[7] 王宇, 徐芳泉, 周旋, 姚晓峰, 李强. 不断提高分化型甲状腺癌根治性切除规范化[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 473-476.
[8] 孙辉, 李长霖. 分化型甲状腺癌根治性切除术中的关键考量与策略[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 477-481.
[9] 高一飞, 刘根祥, 孙长华, 周广军. 喉返神经监测在无充气腋窝入路腔镜单侧甲状腺切除+中央区淋巴结清扫术中的应用效果[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 483-486.
[10] 李伟, 宋子健, 赖衍成, 周睿, 吴涵, 邓龙昕, 陈锐. 人工智能应用于前列腺癌患者预后预测的研究现状及展望[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 541-546.
[11] 皮尔地瓦斯·麦麦提玉素甫, 李慧灵, 艾克拜尔·艾力, 李赞林, 王志, 克力木·阿不都热依木. 生物补片修补巨大复发性腹壁切口疝临床疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 624-628.
[12] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[13] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[14] 王涛, 刘静, 高玉伟, 王兴华, 胡秀红, 崔红蕊, 徐保振, 杨洪娟. 抗生素耐药背景下中医药防治腹膜透析相关性腹膜炎研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 340-344.
[15] 郭曌蓉, 王歆光, 刘毅强, 何英剑, 王立泽, 杨飏, 汪星, 曹威, 谷重山, 范铁, 李金锋, 范照青. 不同亚型乳腺叶状肿瘤的临床病理特征及预后危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 524-532.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?